Aktie CARDIOME PHARMA CORP
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Cardiome Pharma Corp Nasdaq

Aktien

CA14159U3010

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Mark Corrigan Departs as CEO from Correvio Pharma Corp
Justin Renz, CFO Departs from Correvio Pharma Corp
Correvio Pharma Corp. Announces Management Changes
Mercury Pharma Group Limited completed the acquisition of Correvio Pharma Corp..
Correvio Pharma : Obtains Final Order for Plan of Arrangement
Correvio Pharma : Announces Results from Annual General and Special Meeting of Securityholders
Correvio Pharma : Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA
Correvio Pharma Corp. Postpones Announcement of Financial Statements for the First Quarter Ended March 31, 2020
Correvio Pharma : Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19
Correvio Pharma : Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA
Correvio Pharma : Obtains Interim Order For Plan Of Arrangement
Correvio Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2019
Correvio Pharma : Reports Full Year 2019 Financial Results
Correvio Pharma Corp. Auditor Raises 'Going Concern' Doubt
CORREVIO PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Correvio Pharma Corp. - CORV
Correvio Pharma : ADVANZ PHARMA to Acquire Correvio
Mercury Pharma Group Limited entered into an arrangement agreement to acquire Correvio Pharma Corp. for $21.3 million.
Correvio Pharma : Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed Securities
Correvio Pharma : Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events
Correvio Pharma Corp. Receives Complete Response Letter from U.S. FDA for Brinavess and Provides Update on Recent Events
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2JL87 Aktie
  4. Aktie
  5. Nachrichten Cardiome Pharma Corp
  6. Andere Sprachen